Built for high-needs patients: Bluestone’s take on Medicare’s new LEAD Model

Medicare has long had a quiet but serious problem: it pays for visits, not complexity. For primary care practices caring for patients with dementia, mobility challenges, or serious illness, the hours of coordination, home visits, and end-of-life planning simply aren’t reimbursed. Practices that served these patients anyway did so at a financial cost the system was never designed to support.

Bluestone has operated in this reality since 2006, delivering team-based primary care directly to patients in senior living communities. We deliver the care our patients need, and have adopted value-based care programs like the Medicare Shared Savings Program to do it sustainably. Since 2022, Bluestone Accountable Care Organization (ACO) has ranked in the top 5 nationally in Medicare savings for patients who are navigating some of the most complex health journeys in the country. 

This model hasn’t been accessible for smaller practices caring for patients with complex health needs. Now, the payment system is finally catching up. The Centers for Medicare & Medicaid Services’ (CMS) new LEAD (Long-term Enhanced ACO Design) Model is rewriting the rules for how independent primary care practices get paid for caring for Medicare patients. Like the broader industry, we are cautiously optimistic: here’s our take on what stands out.

What excites us

For the first time, the financial structure actually matches the clinical reality of caring for patients with complex health needs. 

1. Complexity is funded: In Medicare’s fee-for-service model, a practice caring for a patient with multiple chronic conditions received roughly the same payment as one seeing a healthy retiree for a checkup — despite the fact that patients with complex conditions cost far more to care for well. LEAD changes that by tying payments to patient complexity and offering a lower barrier of entry for practices serving high cost patients, which is a structural correction to the payment model.
   
2. Prospective payments make a different kind of care possible: Instead of billing for each encounter or waiting for a year-end reconciliation check, practices receive monthly payments upfront. This means they could hire a care manager to manage needs between visits or invest in the technology to track a patient across the ER, the specialist’s office and home. Value-based care programs made versions of this possible before but never at the scale and with the long-term stability that LEAD creates.
   
3. 10-years of stability: LEAD locks your financial target for a decade, meaning if you build something that works, you benefit from it over time. That’s a meaningful departure from how value-based care programs have operated to date: if a practice does well — reduces hospitalizations, improves outcomes, saves money — the gains are eroded over time, known as the ratcheting effect. It’s a tension we’ve navigated firsthand, improving our savings rate every year since joining the MSSP in 2020. For the first time, serious investment in care model transformation has a financial logic that holds long enough to pay off. 

What we’re watching carefully

We’re enthusiastic about LEAD. We’re also realistic about implementation because we’ve lived it through our successful participation in the Medicare Shared Savings Program.

• The incentive to coordinate care is not the same as the infrastructure to do it: LEAD gives practices the financial incentive to coordinate care. It does not give them the tools to do it. Knowing when a patient was admitted to the ER at 2 a.m., following up after a specialist visit, managing transitions out of a skilled nursing facility — these require team members, technology and workflows that most independent practices haven’t built. The incentive is there. The infrastructure still has to be created.
• Bringing specialists into accountability is the right idea and genuinely hard: One of the persistent frustrations of primary care under value-based models is being held accountable for costs you don’t fully control. A specialist orders an expensive test. A patient ends up in the wrong facility after a hospital stay. That cost lands on the primary care practice’s scorecard. LEAD’s CARA mechanism is designed to bring specialists into shared accountability, which is the right direction. We’re watching carefully to see how it develops in practice, particularly around what happens after hospitalizations, end-of-life transitions and managing decline over time. 
• Capital without a care model is just risk: Upfront payments are an opportunity and a test at the same time. Practices that receive monthly payments without the care model to deploy them effectively will find those resources disappearing quickly and performance suffering over a 10-year horizon. The funding enables the work. It doesn’t replace it. This is where partner selection and care model readiness matter most. 

What you should consider if you’re looking at this model

CMS set a goal to move all Medicare beneficiaries into value-based care arrangements by 2030, and LEAD is the clearest signal yet of how they plan to get there. For independent primary care practices, the question is no longer whether value-based care is coming. It’s whether you are ready.

1. Look at your patients: Start by looking honestly at your patient population. LEAD is structurally designed for practices serving patients navigating complexity — those with multiple chronic conditions, cognitive impairment, limited mobility or advanced illness. If that describes a significant portion of your Medicare panel, LEAD was built with you in mind.
2. Look at your care model: Can you deliver care where patients actually live — in their homes, in assisted living, in skilled nursing facilities — or does your model depend on patients coming to you? Do you have the team and systems to manage patients between visits? These are practical questions, and the answers should drive your decision.
3. Look at partnership: LEAD is a 10-year commitment that requires population health infrastructure, care management and experience with high-needs populations. Independent practices can build those capabilities over time, but it takes years and investment. The alternative is joining an ACO that has already made those investments and demonstrated they work. That’s not the right path for every practice. But for those looking to reduce risk while accessing a proven model, it’s worth serious consideration.

Where we stand

LEAD isn’t a new direction for Bluestone — it’s CMS recognizing what we’ve been doing for 20 years. Our results reflect that investment: more than $90 million in Medicare savings since 2020, three consecutive years of top national rankings, and a care model where more than 80% of our patients die on hospice — a reflection of care aligned with patient goals rather than defaulting to high-cost intervention at the end of life.

We’re actively partnering with independent practices that want to succeed under a model that finally rewards doing this work well. If you’re evaluating value-based care including LEAD or MSSP participation, reach out. We’re happy to share what we’ve learned and how to ensure your practice is ready for the next decade of care.